Novel universal vaccine presenting system

The European patent WO2022218997, filed by Pascal Fender’s team (IBS/MEM), protects a universal vaccine platform. Entirely protein-derived and thermostable, it allows the spontaneous and irreversible display of complex antigens using a ’plug and display’ technology.
Preclinical studies have shown its efficacy in the field of emerging infectious diseases such as coronaviruses (Chevillard et al., Mol Ther 2022, and in oncology in the context of melanoma (Besson et al., Biomedicines 2022, and Besson et al., Mol Ther Meth Clin Devpt 2022,
This patent is the subject of both a maturation and start-up incubation programme by SATT Linksium.